Page last updated: 2024-08-25

nedaplatin and Ovarian Neoplasms

nedaplatin has been researched along with Ovarian Neoplasms in 31 studies

Research

Studies (31)

TimeframeStudies, this research(%)All Research%
pre-19903 (9.68)18.7374
1990's8 (25.81)18.2507
2000's6 (19.35)29.6817
2010's11 (35.48)24.3611
2020's3 (9.68)2.80

Authors

AuthorsStudies
Li, Y; Wu, J; Zhu, G1
Chikazawa, K; Imai, K; Ishiguro, A; Kimura, A; Konno, R; Kuwata, T; Netsu, S; Wang, L1
Endo, Y; Fujimori, K; Furukawa, S; Kamo, N; Manabu, K; Nishigori, H; Nomura, S; Okabe, C; Sato, T; Soeda, S; Takahashi, T; Ueda, M; Watanabe, T1
Fujiwara, K; Ogasawara, A; Shintani, D; Yoshida, H1
Chen, J; Ding, Y; Ma, L; Zhang, L; Zhuang, Y1
Jiang, H; Sheng, WJ; Wu, DL; Zheng, JH1
Hu, T; Liu, H; Shi, Y; Song, SQ; Zhang, GN1
Asami, Y; Iiba, M; Kitagawa, R; Kondo, K; Sato, N; Sugita, M; Tadauchi, K; Tsunoda, H; Uenoyama, A1
Gao, H; Han, Y; Yuan, L1
Fujiwara, K; Goto, T; Hasegawa, K; Iwasa, N; Nagao, S; Ohishi, R; Shimizu, M; Takano, M1
Fujiwara, H; Itamochi, H; Kigawa, J; Machida, S; Oishi, T; Sato, S; Shimada, M; Suzuki, M; Takei, Y1
Ota, T; Takeshima, N; Takizawa, K1
Dai, HY; Huang, XE; Li, SY; Shi, FF; Su, XY; Tan, HY; Yin, HT1
Duan, Z; Hu, P; Yue, Y; Zhou, X1
Maekawa, R; Uchida, N; Yamada, H; Yoshioka, T1
Kamiura, S; Morishige, K; Ohta, Y; Saji, F; Yamamoto, T1
Ichikawa, Y; Nishida, M; Tsunoda, H; Yoshikawa, H1
Feng, FY; Gao, YJ; Guan, XQ; Hu, Y; Li, CW; Liu, JW; Nan, KJ; Suo, AL; Wang, XW; Wu, LY; Zhang, MH; Zhang, P; Zhang, WD; Zhang, Y; Zhao, JB1
Jobo, T1
Eastman, A; Hom, DK; Howell, SB; Isonishi, S1
Ota, K1
Adair, LP; Alberts, DS; Fanta, PT; Garcia, DJ; Liu-Stevens, R; Running, KL; Salmon, SE1
Fujii, H; Igarashi, T; Itoh, K; Kodama, K; Minami, H; Ohtsu, T; Sasaki, Y; Wakita, H; Watanabe, Y; Yamashita, T1
Adachi, S; Beppu, K; Chin, R; Hori, K; Itani, Y; Ito, K; Kawai, S; Koyama, M; Saito, K; Shintani, M1
Daikatsu, K; Ikeuchi, I; Maekawa, R; Sugita, K; Uchida, N; Wada, T; Yamada, H; Yoshida, H; Yoshioka, T1
Kubo, T; Nishida, M; Nishide, K; Satoh, Y; Tsunoda, H1
Hongo, A; Kawanishi, K; Kodama, J; Kudo, T; Miyagi, Y; Nakamura, K; Yamamoto, J; Yoshinouchi, M1
Arai, M; Kato, T; Nishimura, H; Noda, K; Ota, M; Suzuki, M; Takamizawa, H; Takeuchi, S; Terashima, Y; Yakushiji, M1
Suzumori, K; Yagami, Y; Yasui, Y1
Nishimura, H; Yakushiji, M1
Hamaguchi, K; Kato, T; Kishi, N; Matsumura, T; Miyahara, K; Nishimura, H; Tashiro, M; Yakushiji, M1

Reviews

1 review(s) available for nedaplatin and Ovarian Neoplasms

ArticleYear
[Cisplatinum compounds].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Prostatic Neoplasms; Testicular Neoplasms

1993

Trials

8 trial(s) available for nedaplatin and Ovarian Neoplasms

ArticleYear
Evaluation of a formula for individual dosage of nedaplatin based on renal function.
    Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Blood Platelets; Female; Humans; Kidney; Kidney Function Tests; Metabolic Clearance Rate; Middle Aged; Models, Theoretical; Organoplatinum Compounds; Ovarian Neoplasms; Platelet Count; Precision Medicine; Predictive Value of Tests; Uterine Cervical Neoplasms

2012
[Combination chemotherapy with nedaplatin and paclitaxel for ovarian cancer].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 10

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Gynecologic Surgical Procedures; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Thrombocytopenia; Treatment Outcome

2004
[Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Esophageal Neoplasms; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leukopenia; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Organoplatinum Compounds; Ovarian Neoplasms; Vinblastine; Vinorelbine

2006
[Cisplatinum compounds].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Prostatic Neoplasms; Testicular Neoplasms

1993
A dose-finding study of nedaplatin and cyclophosphamide for patients with gynecological malignancies.
    Japanese journal of clinical oncology, 1999, Volume: 29, Issue:6

    Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Disease Progression; Drug Administration Schedule; Erythrocyte Count; Feasibility Studies; Female; Humans; Infusions, Intravenous; Leukocyte Count; Middle Aged; Neutrophils; Organoplatinum Compounds; Ovarian Neoplasms; Platelet Count; Remission Induction; Survival Rate; Uterine Cervical Neoplasms

1999
[Phase I study of a combination chemotherapy of nedaplatin and cisplatin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:14

    Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Uterine Cervical Neoplasms

1999
[Phase II study of 254-S (cis-diammine glycolato platinum) for gynecological cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:5

    Topics: Adult; Aged; Anorexia; Antineoplastic Agents; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms; Vomiting

1992
[Current status of CDDP analogs in gynecologic malignancies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:4 Pt 2-2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Double-Blind Method; Doxorubicin; Drug Evaluation; Female; Genital Neoplasms, Female; Humans; Japan; Middle Aged; Multicenter Studies as Topic; Organoplatinum Compounds; Ovarian Neoplasms; Remission Induction; Uterine Cervical Neoplasms

1989

Other Studies

23 other study(ies) available for nedaplatin and Ovarian Neoplasms

ArticleYear
Efficacy Analysis of Comprehensive Nursing in the Care of Ovarian Carcinoma Treated with Paclitaxel Combined with Nedaplatin.
    Computational and mathematical methods in medicine, 2022, Volume: 2022

    Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Nerve Growth Factor; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel

2022
Nedaplatin use in patients with hypersensitivity reaction episodes to carboplatin.
    Taiwanese journal of obstetrics & gynecology, 2020, Volume: 59, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Case-Control Studies; Drug Hypersensitivity; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Retrospective Studies

2020
Successful Management of Platinum-resistant Ovarian Cancer by Weekly Nedaplatin Followed by Olaparib: Three Case Reports.
    Anticancer research, 2020, Volume: 40, Issue:9

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Combined Modality Therapy; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Phthalazines; Piperazines; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed; Treatment Outcome

2020
Feasibility and response to nedaplatin monotherapy in older patients with ovarian cancer.
    Archives of gynecology and obstetrics, 2017, Volume: 296, Issue:4

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Feasibility Studies; Female; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Retrospective Studies; Treatment Outcome

2017
A rare case report of ovarian juvenile granulosa cell tumor with massive ascites as the first sign, and review of literature: Case report and review of literature.
    Medicine, 2018, Volume: 97, Issue:25

    Topics: Abdominal Cavity; Antineoplastic Agents; Ascites; CA-125 Antigen; Chemotherapy, Adjuvant; Female; Granulosa Cell Tumor; Humans; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Salpingo-oophorectomy; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography; Young Adult

2018
Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2013, Volume: 46, Issue:8

    Topics: Animals; Antineoplastic Agents; Apoptosis Regulatory Proteins; bcl-X Protein; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Migration Assays; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Gene Expression; Humans; Inhibitor of Apoptosis Proteins; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Oxazines; Rats; Signal Transduction; STAT3 Transcription Factor; Survivin; Vascular Endothelial Growth Factor A; Xanthenes

2013
Addition of bevacizumab to neoadjuvant chemotherapy for Stage IV ovarian serous adenocarcinoma with multiple lymph node metastases: a case report.
    European journal of gynaecological oncology, 2015, Volume: 36, Issue:3

    Topics: Adenocarcinoma; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Chemoradiotherapy, Adjuvant; Female; Humans; Lymph Nodes; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Cystic, Mucinous, and Serous; Organoplatinum Compounds; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Treatment Outcome

2015
[A Patient with Recurrent Ovarian Cancer Who Was Hypersensitive to Carboplatin Exhibited Complete Response to Gemcitabine and Nedaplatin].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; Drug Hypersensitivity; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Recurrence

2015
Comparisons of the survival time of patients with ovarian cancer adopting post-operative chemotherapy by use of paclitaxel combined with carboplatin or nedaplatin.
    World journal of surgical oncology, 2016, Jun-24, Volume: 14, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Cystadenocarcinoma, Serous; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Postoperative Care; Prognosis; Survival Rate

2016
Single nedaplatin treatment as salvage chemotherapy for platinum/taxane-resistant/refractory epithelial ovarian, tubal and peritoneal cancers.
    The journal of obstetrics and gynaecology research, 2010, Volume: 36, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma; Disease-Free Survival; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Peritoneal Neoplasms; Salvage Therapy; Treatment Outcome

2010
Second-line chemotherapy for carboplatin/paclitaxel-refractory ovarian cancer: are multi-agent chemotherapies of little value truly?
    European journal of gynaecological oncology, 2011, Volume: 32, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Humans; Irinotecan; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids

2011
Intervention effects of nedaplatin and cisplatin on proliferation and apoptosis of human tumour cells in vitro.
    Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:9

    Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma; Cell Proliferation; Cisplatin; Drug Synergism; Esophageal Neoplasms; Female; HeLa Cells; Humans; Inhibitory Concentration 50; Ki-67 Antigen; Organoplatinum Compounds; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger

2012
A case of occult bowel perforation after a cycle of chemotherapy for advanced epithelial ovarian carcinoma.
    European journal of gynaecological oncology, 2012, Volume: 33, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma, Ovarian Epithelial; Female; Humans; Intestinal Perforation; Neoadjuvant Therapy; Neoplasms, Glandular and Epithelial; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel

2012
[Combination chemotherapy of paclitaxel followed by nedaplatin for human ovarian cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:11

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel

2002
Complete response to irinotecan hydrochloride and nedaplatin in a patient with advanced ovarian clear cell carcinoma.
    International journal of clinical oncology, 2004, Volume: 9, Issue:5

    Topics: Adenocarcinoma, Clear Cell; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Female; Humans; Irinotecan; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Parity; Treatment Outcome

2004
[Outpatient chemotherapy in gynecologic oncology].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33 Suppl 2

    Topics: Ambulatory Care Facilities; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Female; Humans; Irinotecan; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Uterine Cervical Neoplasms; Uterine Neoplasms

2006
Enhancement of sensitivity to platinum(II)-containing drugs by 12-O-tetradecanoyl-phorbol-13-acetate in a human ovarian carcinoma cell line.
    British journal of cancer, 1994, Volume: 69, Issue:2

    Topics: Carboplatin; Cisplatin; Cystadenocarcinoma, Serous; DNA, Neoplasm; Drug Synergism; Enzyme Activation; Female; Glutathione; Glutathione Transferase; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Protein Kinase C; Pyrazoles; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1994
In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancers.
    Cancer chemotherapy and pharmacology, 1997, Volume: 39, Issue:6

    Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Drug Screening Assays, Antitumor; Female; Humans; Organoplatinum Compounds; Ovarian Neoplasms

1997
Successful treatment with nedaplatin in patients with ovarian cancer that recurred after platinum-containing chemotherapy: report of two cases.
    Japanese journal of clinical oncology, 1998, Volume: 28, Issue:5

    Topics: Adenocarcinoma, Papillary; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Ovarian Neoplasms

1998
Combination chemotherapy with nedaplatin and cyclophosphamide in human ovarian cancer model.
    Japanese journal of cancer research : Gann, 1999, Volume: 90, Issue:8

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Body Weight; Cell Division; Cisplatin; Cyclophosphamide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Ovarian Neoplasms; Survival Rate; Tumor Cells, Cultured

1999
Cytocidal effect and DNA damage of nedaplatin in vitro by simulating pharmacokinetic parameters.
    Cancer chemotherapy and pharmacology, 2001, Volume: 47, Issue:4

    Topics: Antineoplastic Agents; Area Under Curve; Cell Survival; Colony-Forming Units Assay; Cross-Linking Reagents; Culture Media; DNA Damage; DNA, Neoplasm; Female; Half-Life; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Tumor Cells, Cultured

2001
[Comparative studies of the antitumor activities of CDDP and the analogs--using gynecological carcinomas transplanted into nude mice].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:3 Pt 1

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Ovarian Neoplasms; Prognosis; Transplantation, Heterologous; Uterine Neoplasms

1989
Antitumor activity of cisplatin analogs against malignant ovarian tumor xenografts into nude mice.
    Nihon Sanka Fujinka Gakkai zasshi, 1988, Volume: 40, Issue:11

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Line; Cisplatin; Cystadenocarcinoma; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Ovarian Neoplasms

1988